 Company receives 14.2M in grants from the Bill Melinda Gates Foundation to support the TB tests ongoing development and future launch into developing countries LONDON, Dec. 14, 2022 GLOBE NEWSWIRE LumiraDx Limited Nasdaq: LMDX, a next-generation point of care diagnostics company, today announced it has received 14.2M in grants from the Bill Melinda Gates ... The post LumiraDx Announces New Investment for Ongoing Development of its Point of Care Molecular Tuberculosis Test appeared f... 